DARE 12-Month Stock Price Forecast
Historical performance and analyst price target projections
Loading chart...
- Highest Price Target
- $-
- Average Price Target
- $-
- Lowest Price Target
- $-

Daré Bioscience, Inc. (DARE)
DARENASDAQHealthcareBiotechnology
As of Nov 20, 2026 close
Analyst consensus ratings, 12-month price targets, and expert recommendations for Daré Bioscience, Inc. stock.
Investment consensus from 1 professional research analysts
Loading chart...
Historical performance and analyst price target projections
Loading chart...
Recent analyst recommendations with rating changes and price target updates (last 90 days)
| Date | Analyst | Firm | Action | Rating | Price Target |
|---|---|---|---|---|---|
| Zacks Equity Research | Zacks Equity Research | Initiates Coverage | Hold | - |
Source: Professional analyst ratings and price targets from the last 90 days. Data as of Nov 16, 2026. Data sources and methodology
The analyst consensus rating for DARE is Hold, based on the latest rating from each of 1 analyst over the 90 days to Nov 16, 2026. Of those, 1 Hold.
Of the 1 analyst rating published for DARE in the 90 days to Nov 16, 2026, none raised or lowered a previously reported price target. No analyst upgraded or downgraded the stock over the same period.